Potential Therapy For Congenital Muscular Dystrophy

January 2 2009

Current research suggests laminin, a protein that helps cells stick together, may lead to enhanced muscle repair in muscular dystrophy. The related report by Rooney et al, "Laminin-111 restores regenerative capacity in a mouse model for alpha 7 integrin congenital myopathy," appears in the January 2009 issue of The American Journal of Pathology. Muscular dystrophy is a group of inherited genetic diseases that cause progressive muscle weakness.

Congenital Muscular Dystrophy

A group of diseases causing muscle weakness at birth. Several defined genetic mutations cause muscles to break down faster than they can repair or grow. A child with CMD may have various neurological or physical impairments. Some children never gain the ability to walk, while others lose the ability as they grow older. Learn more...
Events
- CMD Research and Therapeutic Development Working Group
  - 13 September 2010
- CMD Translational Grant Deadline
  - 15 September 2010
- Conference on Clinical Research for Rare Diseases
  - 21 September 2010
  - Bethesda, MD
- Cure CMD and NINDS: Common Data Elements Project meeting
  - 29 September 2010
- Team Cure CMD walks/runs San Jose Rock N Roll 1/2 Marathon
  - 3 October 2010
Cure CMD Channel
Friends of Cure CMD
Navigation
Show Sub-Pages | Hide Sub-Pages

This website is for the discussion of Congenital muscular dystrophy (CMD) research, treatment and care issues. Please note that the ideas posted are the views of the individual, who may or may not be a licensed professional. Please consult with your doctors before implementing any treatment suggested here.

Copyright © Cure CMD | Designed by PressEnter! Creative | Powered by WordPress + Thematic, Events Manager, Sitemaps, Lightbox, Aggregation, TinyMCE, dTree, Category Posts

Potential Therapy For Congenital Muscular Dystrophy

January 2 2009

Congenital Muscular Dystrophy

Events

Navigation